Australian researchers at ANU identify immune protein NLRC4 as a potential biomarker and treatment for bowel cancer.

Australian researchers at the Australian National University (ANU) have identified an immune protein, NLRC4, that may aid in developing new bowel cancer treatments. NLRC4 can repair damaged DNA, preventing healthy cells from becoming cancerous. Its reduced presence in bowel cancer patients suggests it could serve as a biomarker for predicting outcomes. Early detection of bowel cancer is vital, as nearly 99% of cases are treatable when diagnosed early.

October 21, 2024
6 Articles